Abstract:This study was aimed to summarize and analyze the clinical features and biological characteristics of adult acute T-lymphoblastic leukemia (T-ALL), and compare the efficacy of chemotherapy and transplantation in order to explore the factors influencing the long term survival and prognosis. Twenty-two T-ALL patients, all of whom were initially diagnosed according to MICM classification criteria from May 2000 to May 2010, were enrolled in this study. All patients received VDCLP regimen as the induction chemotherapy. In consolidation stage, some of the patients received allogeneic hematopoietic stem cell transplantation (allo-HSCT) and the others underwent intensive chemotherapy. The clinical and laboratory parameters were summarized and the contribution to survival and efficacy was analyzed by using χ(2) test, Kaplan-Meier method, Cox regression analysis and log-rank test with the aid of SPSS13.0 software. The results showed that: (1) The median age of all 22 patients was 23.5 years (16 - 63 years). 15 patients with splenomegaly had much shorter event-free survival (EFS) period (P = 0.014) and overall survival (OS) period (P = 0.013). The median white blood cell (WBC) count was 148.82 (5.51-546.0) × 10(9)/L. 15 cases out of them had leucocytosis (WBC ≥ 80 × 10(9)/L), whose EFS period (P = 0.021) and OS time (P = 0.050) were reduced significantly. The similar condition was observed in 6 patients whose blood platelet (Plt) count was no more than 30 × 10(9)/L (P = 0.033 for EFS and P = 0.035 for OS, respectively); (2) Immunophenotypic analysis showed that from 22 cases 2 cases were of pro-T, 14 cases of pre-T, 3 cases of cortical-T and 3 cases of medullary-T. Supposing pro-T and pre-T as earlier period immunophenotype, cortical-T and medullary-T as advanced stage immunophenotype, there were significant differences between earlier period and advanced stage patients in terms of EFS and OS (P = 0.035 for EFS and P = 0.028 for OS, respectively); (3) Chromosome karyotype was analyzed in 19 cases at diagnosis, and among them 12 cases had normal karyotypes while abnormal karyotypes were observed in 7 cases. Correlation analysis showed that there were no significant differences between these two groups in time of EFS and OS; (4) The overall complete remission (CR) rate was 72.7 after the induction chemotherapy. The median CR period was 18.0 months. The EFS and OS rate were 57.9 and 67.1 for 1-year, and 23.0 EFS rate and 22.0 OS rate for 3-years, respectively. Six patients received allo-HSCT and the average EFS time and OS time were both 57.8 months, which were significantly longer than those of the intensive chemotherapy group (P = 0.001 and P = 0.002 for EFS and OS, respectively); (5) Cox regression analysis proved that allo-HSCT treatment was the independent favorable prognostic factor. It is concluded that higher CR rate can be achieved by using intensive induction chemotherapy in adult T-ALL, but the long term survival seems poor by chemotherapy only in consolidation treatment stage. Allo-HSCT is the optimal choice to improve the prognosis and the outcome.

Gamma-Delta T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Immunophenotype of Three Adult Cases

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases

MICM Classifications Analysis of Adult Acute Lymphoblastic Leukemia

Gamma-delta T-cell acute lymphoblastic lymphoma/leukemia: a report of a rare entity

Pediatric cutaneous T‐cell neoplasm and mimics with gamma‐delta expression: Not always aggressive

[Characteristics of T-cell Lineage Immunophenotype in 95 Patients with Acute Lymphoid Leukemia].

[Probe of Classification of Adult Acute Lymphoblastic Leukemia].

Immunophenotyping of 222 Children with Acute Leukemia by Multi-Color Flow Cytometry

Analysis of Immunophenotype of Acute Lymphoblastic Leukemia and Clinical Presentations and Prognosis in Children

Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry]

Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States

Immunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults]

[Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia]

[Characteristics of 4 specific target antigens in adult acute lymphoblastic leukemia]

Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype

Therapy-Related Acute Lymphoblastic Leukemia Without 11q23 Abnormality Report Of Six Cases And A Literature Review

Clinicopathological analysis of adult lymphoblastic lymphoma

Transformation of T-Cell Acute Lymphoblastic Lymphoma to Peripheral T-Cell Lymphoma: A Report of Two Cases

[Clinical Analysis on Adult Acute T-lymphoblastic Leukemia].

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

[Clinical Features and Therapeutic Efficacy in Adult Acute Lymphoblastic Leukemia with T (1; 19) (E2A-PBX1)].